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This study sought to assess the effects of an inactivated phase I vaccine 
against Coxiella burnetii at the start of the third trimester of gestation on serologi-
cal profiles, bacterial shedding patterns and subsequent reproductive performance 
in dairy cows. Cows were randomly assigned to a control (n = 78) or a vaccinated 
(n = 78) group on days 171–177 of gestation. Samples of placenta and colostrums 
at parturition, vaginal fluid, faeces, milk (PCR identification) and blood (anti-C. 
burnetii antibody detection) were obtained on the day of treatment and on days 
91–97 post partum, and also on parturition day and weekly on days 1–7, 8–14, 
15–21, 22–28 and 29–35 post partum in a subset of 70 animals. By Kaplan–Meier 
survival analysis, no significant effect of vaccination was detected on any of the 
reproductive variables studied. According to the odds ratio, C. burnetii shedding 
on days 171–177 of gestation was highly correlated with seropositivity against C. 
burnetii (OR = 9.1), while vaccination was not linked to reduced shedding of the 
bacterium. In shedders compared to others, the likelihood of pregnancy to first AI 
decreased and increased by factors of 0.26 and 16.1 on days 1–35 and 91–97 post 
partum, respectively. In conclusion, when administered at the start of the third 
trimester of pregnancy, the inactivated C. burnetii phase I vaccine failed to reduce 
bacterial shedding. 
Key words: Coxiella burnetii, vaccination, shedding, infection, reproduction, 
pregnancy loss, bovine, infertility 
Q fever is a re-emerging zoonotic disease caused by Coxiella burnetii, an 
obligate intracellular, Gram-negative bacterium. Coxiellosis in humans has been 
widely investigated and is known to produce mainly a flu-like syndrome and 
abortion. Domestic ruminants are the main reservoir and source of infection for 
humans (Arricau-Bouvery and Rodolakis, 2005). Although the effects of C. bur-
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netii on small ruminants have been clearly established, reports of its impacts in 
cattle have been contradictory. Thus, some research efforts in dairy cattle have 
related the presence of specific antibodies against C. burnetii to reproductive dis-
orders such as retained placenta or reduced fertility (López-Gatius et al., 2012), 
while other studies have observed no such relationship (Garcia-Ispierto et al., 
2011). In addition, it has been reported that shedding cows are not always sero-
positive for C. burnetii and that not all seropositive animals shed the bacterium 
(Hansen et al., 2011). To further complicate matters, there are three possible 
shedding routes: via the milk, vaginal mucous or faeces (Guatteo et al., 2006); 
making it very difficult to detect this infection at the clinical level. Finally, verti-
cal transmission has not been demonstrated by serology (Tutusaus et al., 2013). 
Several vaccines against C. burnetii have been recently developed. So far, 
the phase I inactivated vaccine seems to be the most protective, inducing sero-
conversion and reducing bacterial shedding and abortion rates in seronegative 
and/or PCR-negative goats (de Cremoux et al., 2012). However, in dairy cattle, a 
Th2 immune response and reduced shedding has been observed only in non-
pregnant animals that are seronegative and/or PCR-negative (Guatteo et al., 
2008). Further, to the best of our knowledge, phase I vaccination has been only 
tested in the early post-insemination period or in the very early stages of embry-
onic development (Taurel et al., 2012). Given that, because of farm management 
policy, vaccination after artificial insemination (AI) is sometimes difficult, this 
study sought to determine the effect of an inactivated phase I vaccine against C. 
burnetii given at the starting of the third trimester of gestation (on days 171–177) 
on serological profiles, shedding patterns and the reproductive status of high-
producing pregnant dairy cows. To this end, cows were monitored for antigen 
shedding and antibody production during the prepartum, periparturient and post-
partum period (on a weekly basis), and also on days 91–97 post partum. 
 
 
Materials and methods 
The study was performed in two commercial Holstein-Friesian dairy herds 
in northeastern Spain, comprising 625 and 125 lactating animals, respectively, 
from October 2010 to October 2011. Cows were milked three times daily with a 
mean annual milk production of 11,343 kg and 9,846 kg for Herds 1 and 2, re-
spectively. The cows calved all year round and were fed complete rations, in line 
with the National Research Council recommendations (2001). During the study 
period, mean calf mortality rate was 9% and mean conception rate was 33% for 
the two herds. 
Vaccination programmes for the prevention of bovine viral diarrhoea 
(BVD) and infectious bovine rhinotracheitis (IBR) involved the use of modified 
live vaccines (Cattlemaster®, Pfizer, New York, USA) for animals 6–8 months 
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old. Pregnant animals were given killed vaccines (Triangle 4®, Boehringer Ingel-
heim, Barcelona, Spain) during the eighth months of each gestation period. 
Parous cows that were not pregnant on day 150 post partum received a further 
killed vaccine. The presence of C. burnetii DNA in the bulk tank milk (BTM) was 
detected by polymerase chain reaction (PCR) in both herds with an excretion level 
higher than 103 Coxiella/ml (Garcia-Ispierto et al., 2010, 2011; López-Gatius et 
al., 2012) and C. burnetii seroprevalence in Herds 1 and 2 was 28.2 and 18%, re-
spectively. According to the results of previous ELISA and PCR tests on BTM 
samples, both herds were known to be chronically infected with Coxiella burnetii. 
Only animals free of clinical disease during the study period were in-
cluded in the study. Exclusion criteria were mastitis, lameness and digestive dis-
orders. These animals were excluded to minimise variations in the general health 
status of the animals so that serological changes could be attributed to factors 
other than the clinical condition of the cows during the study. Eventually, the 
data of a total of 156 cows were analysed. 
Insemination and pregnancy diagnosis 
Oestrus was detected using a pedometer system (AfiFarm System; SAE 
Afikim, Israel). Walking activity values were recorded at the milking parlour 
(three times daily) and analysed automatically using the herd management com-
puter programme (López-Gatius et al., 2005). Cows that exhibited oestrus within 
a 12-day interval were also excluded and registered as cows with possible repro-
ductive disorders. These animals were returned to a weekly gynaecological ex-
amination programme. Cows were finally inseminated after oestrus had been 
confirmed by examination of the genital tract and vaginal fluid. Pregnancy diag-
nosis was performed by ultrasound 28–34 days after insemination and confirmed 
on days 90–96 after insemination. Foetal loss was recorded when the days 90–96 
diagnosis proved negative. Cows diagnosed as not pregnant and cows with no 
oestrous signs before days 71–77 in milk were included in a weekly reproductive 
programme and inseminated either following specific treatment (López-Gatius et 
al., 2008) or during natural oestrus. Data from cows suffering from any clinical 
disease before day 120 in milk (open cows) or before day 90 of gestation (preg-
nant cows) were withdrawn from the study. All gynaecological examinations and 
pregnancy diagnoses were performed by the same veterinarian. 
Experimental design 
At the beginning of the study, individual serological tests were performed 
in heifers (older than 12 months) and parous cows to determine the anti-C. bur-
netii antibody status of the herds. After these tests, 156 cows were randomly as-
signed to a control non-vaccinated (n = 78) or vaccinated (n = 78) group. Cows in 
the vaccinated group received two subcutaneous injections 3 weeks apart of inac-
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tivated phase I vaccine (Coxevac®, CEVA Santé Animale, Libourne, France) on 
days 171–177 and days 192–198 of gestation. Each 4-mL vaccine dose contained 
purified corpuscular phase I C. burnetii antigens (100 µg/mL) inactivated with 
formaldehyde. Cows were sampled (blood, milk, vaginal fluid and faeces) twice 
during the study period: on days 171–177 of pregnancy and on days 91–97 post 
partum. The final study population comprised 117 parous animals and 39 heifers. 
A subset of 70 of the 156 cows underwent more intensive monitoring. 
These cows were sampled 8 times during the study period: on days 171–177 of 
gestation, on the day of parturition and on days 1–7, 8–14, 15–21, 22–28, 29–35 
and 91–97 post partum. Besides blood, milk, vaginal fluid and faeces, on the day 
of parturition placenta and colostrum samples were also collected. 
Sampling procedures 
Blood. Blood samples were collected from the coccygeal vein into hepari-
nised vacuum tubes (BD VacutainerTM, Becton, Dickinson and Company, Ply-
mouth, UK). Tubes were centrifuged (10 min, 1600 × g) within 30 min of collec-
tion and the plasma stored at –20 °C until analysis. 
Milk and colostrum. These samples were collected in a plastic sterile con-
tainer for PCR. To minimise the risk of contamination during the collection 
process, teats were washed in clean water and then each teat end was scrubbed 
using an antiseptic wipe. Finally, milk and colostrum were collected from the 
four teats after elimination of the initial stream. Samples were frozen at –20 °C 
prior to analysis. 
Vaginal fluid. To obtain a vaginal fluid sample, the vulva was disinfected 
with iodine solution, and a vaginal swab obtained and stored at –20 °C. 
Faeces. Faecal samples were collected into sterile containers using a rectal 
examination glove and stored at –20 °C. 
Placenta. Specimens of the placenta were obtained immediately after par-
turition. After washing the perineum with iodine solution, three cotyledons were 
excised using rectal palpation gloves. After their collection, the specimens were 
stored at –20 °C until PCR analysis. 
Clinical examination 
During four scheduled herd visits (V1–V4), examinations were performed 
on days 15–21 (V1), 22–28 (V2), 29–35 (V3) and 51–57 (V4) post partum by the 
same veterinarian. The clinical examination included ultrasonography (US) of 
the genital tract and ovaries and examination of vaginal fluid (appearance and 
odour). The entire reproductive tract was examined by ultrasound using a portable 
B-mode ultrasound scanner (Easi-scan® with a 7.5 MHz transducer). In Visit 1, 
cows were classed as suffering from endometritis according to the criteria de-
scribed by López-Helguera et al. (2012): the presence of echogenic intrauterine 
fluid (IUF), a cervical diameter of ≥ 4 cm or an endometrial thickness ≥ 0.75 cm. 
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Laboratory tests 
Antibodies to Coxiella burnetii. Antibodies to C. burnetii were detected in 
plasma samples by indirect enzyme-linked immunosorbent assay (ELISA) using 
the CoxLS kit (LSIVET RUMINANT Milk/Serum Q FEVER®, Laboratoire Ser-
vice International, Lissieu, France). This validated test (García-Pérez et al., 2009) 
was performed according to the manufacturer’s instructions. The sensitivity and 
specificity of ELISA are 85% and 95%, respectively (Courcoul et al., 2010). The 
antigen for the ELISA CoxLS kit was isolated from domestic ruminants by 
INRA in Nouzilly (France). A cocktail of both antigen phases (I and II) was used 
in this assay to detect total anti-C. burnetii immunoglobulin G antibodies (IgG) 
(Guatteo et al., 2008). Results are expressed as optical densities (OD). For each 
sample, the sample-to-positive (S/P) ratio was calculated as follows: sample OD 
minus negative control OD/positive control OD minus negative control OD, and 
expressed as an antibody titre (titre = S/P × 100). 
Polymerase chain reaction. Coxiella burnetii was detected by PCR in the 
samples using a commercial kit targeting the repetitive transposon-like region of 
C. burnetii (LSI Taqvet Coxiella burnetii®; Laboratoire Service International, 
Lissieu, France) according to the manufacturer’s instructions. The positive control 
used was a solution containing 105 C. burnetii/mL (UR INRA IASP, Nouzilly, 
France). The negative control sample used was DNase RNase-free water. DNA 
was extracted from the different samples using the QIAmp DNA minikit® 
(Qiagen S.A., Courtaboeuf Cedex, France) according to the manufacturer’s in-
structions. 
Data collection and statistical analysis 
The following data were recorded for each animal: herd, treatment group 
(vaccination vs. control), parity (primiparous vs. multiparous), stillbirth, repro-
ductive disorders following calving (retained placenta and primary metritis), date 
and season of parturition (cool season: October–April vs. warm season: April–
September), endometritis (0: absence, 1: presence), twinning, milk production at 
50 days post partum (low milk production: less than 40 kg/day; high milk pro-
duction: 40 or more kg/day), and reproductive variables for the subsequent lacta-
tion such as cow cyclicity (presence or absence of a corpus luteum within the 
first 35 days post partum), fertility at first AI, pregnancy rate on day 150 post 
partum, repeat breeding syndrome (four or more AIs), date of the AI resulting in 
pregnancy, pregnancy loss (pregnancy loss before 90 days post partum), anti-C. 
burnetii antibody status on days 171–177 of pregnancy and C. burnetii shedding 
via any of the four possible routes (milk, faeces, vaginal fluid, and the placenta at 
parturition) on days 171–177 of pregnancy, on the day of parturition, and on 
days 1–7, 8–14, 15–21, 22–28, 29–35 and 91–97 post partum. 
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All statistical procedures were performed using the SPSS software package 
version 18.0 (SPSS Inc., Chicago, IL, USA). Significance was set at P < 0.05. 
The variables mean time of return to luteal activity and AI resulting in 
pregnancy for the treatment group were compared with the remaining variables by 
Kaplan-Meier survival analysis. Cows not returning to cyclicity before day 35 post 
partum or culled before 150 days post partum were censored in each analysis. 
Logistic regression was performed on data from each cow using C. bur-
netii shedding (in any type of sample at parturition, on days 1–35 post partum 
and on days 91–97 post partum), C. burnetii seropositivity, pregnancy loss, re-
peat breeding syndrome, fertility at first AI and retained placenta as the depend-
ent variable and the above-mentioned remaining variables as independent fac-
tors. Plausible interactions between factors were also included in the analyses. 
 
 
Results 
The study sample comprised 156 pregnant cows, 78 vaccinated, with a 
mean lactation number of 2.8, ranging from 1 to 6. At the study outset, 66 cows 
were seropositive for C. burnetii (42.3%) and 90 were seronegative. Bacterial 
shedding was observed in 38 (24.4%) and 12 (7.7%) of the dams in the prepar-
tum or postpartum period (in at least one postpartum sample), respectively. All 
cows included in the study delivered at term. After parturition, 26 cows had re-
tained placenta (17%). Eight of the 156 animals included in the study were not 
inseminated due to culling for economic reasons. Forty-four of the inseminated 
cows showed repeat breeding syndrome (29.7%). 
Table 1 
Coxiella burnetii serological profiles and shedding patterns before and after treatment 
Seropositive Seronegative 
Treatment Sampling time PCR + 
n (%) 
PCR – 
n (%) 
PCR + 
n (%) 
PCR – 
n (%) 
Vaccinated (n = 78) 171–177a  13 (16.7) 23 (29.5) 8 (10.3) 34 (43.6) 
 91–97 ppb 4 (5) 58 (74) 1 (1.3) 15 (19) 
Control (n = 78) 171–177a  11 (14) 19 (24.4) 6 (7.7) 42 (53.8) 
 91–97 ppb 5 (6.4) 28 (36) 2 (2.6) 43 (55) 
adays 171–177 of gestation; bdays 91–97 post partum 
 
Serological profiles and shedding patterns for all cows on days 171–177 of 
gestation and days 91–97 post partum are presented in Table 1. Control cows 
seronegative for C. burnetii did not undergo seroconversion during the study pe-
riod, whereas all control seropositive cows remained seropositive. Twenty-six 
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(61.9%) of the vaccinated animals seroconverted after vaccination. The routes of 
shedding during the study period for all cows are shown in Table 2. Figures 1 
and 2 show the changes produced in serological profiles and shedding patterns 
throughout the study period, respectively, in the subgroup of 70 cows. 
Table 2 
Samples giving a positive PCR result for Coxiella burnetii according to the time of collection and 
the shedding route. Percentages refer to the total number of a given sample type for a given period 
Type of sample Days 171–177 of pregnancyn (%) 
Days 91–97 post partum 
n (%) 
Both periods 
n (%) 
Vaginal fluid 5 (3.2) 2 (1.3) 0 (0) 
Faeces 16 (10.3) 5 (3.2) 1 (0.6) 
Milk 14 (9) 1 (0.6) 2 (1.3) 
 
Fig. 1. Antibodies to Coxiella burnetii recorded throughout the study in vaccinated and control 
seropositive cows 
No significant differences were detected by Kaplan-Meier survival analy-
sis in the mean time to pregnancy diagnosis/conception until day 150 post par-
tum and to return to luteal activity until day 35 post partum for any of the vari-
ables examined. 
According to the odds ratio, the likelihood of C. burnetii shedding after 
171–177 days of pregnancy was 9.1 times higher in C. burnetii seropositive cows 
than seronegative cows (P = 0.004), while vaccination had no effect on shedding. 
In shedding cows compared to non-shedding animals, the likelihood of preg-
nancy to first AI was reduced by a factor of 0.26 (P = 0.03) and increased by a 
factor of 16.1 (P = 0.02) on days 1–35 and days 91–97 post partum, respectively. 
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Fig. 2. Percentages of cows in the vaccinated and control groups shedding Coxiella burnetii by at 
least one route (milk, faeces, vaginal fluid, or placenta at parturition) throughout the study 
 
 
Discussion 
As far as we are aware, the pertinent literature lacks reports on C. burnetii 
vaccination trials conducted during advanced pregnancy in high-producing dairy 
cows. Despite several descriptions of reduced shedding loads produced in re-
sponse to vaccination against C. burnetii (de Cremoux et al., 2012), the present 
findings suggest there is no link between vaccination and shedding load in preg-
nant cows. These results are consistent with those of other studies performed in 
animals vaccinated after AI (Guatteo et al., 2008). Probably, the inefficiency of 
the vaccine in pregnant animals is due to hormonal changes produced in preg-
nancy. During gestation, there is a shift towards the Th2 immune response at the 
expense of Th1, the cellular immune response (Druckmann and Druckmann, 
2005) which could interfere with the response to vaccination. Thus, vaccinating 
all animals on farms with herds chronically infected with C. burnetii may not be 
an effective measure to reduce shedding. 
Cows observed here to shed the bacterium on days 91–97 post partum showed 
improved subsequent fertility at first AI over non-shedders. This observation is in 
agreement with our suggestion based on prior findings (Garcia-Ispierto et al., 2012) 
that non-infected animals are not protected against the bacterium and consequently 
may be more susceptible to infection. However, cows shedding during the first five 
weeks post partum showed a lower fertility at first AI than non-shedders over this 
period. Recently, vaccination in goats was reported to increase milk shedding from 
hours to 9 days or more after vaccination (Hermans et al., 2011). Thus, it could be 
that postvaccination shedding masks shedding patterns within the first weeks of vac-
cination. Future studies should try to determine whether cows shed live bacteria after 
vaccination or, in other words, whether the difference between control and vacci-
nated animals is simply that vaccinated cows shed dead bacteria. 
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A seroconversion rate of 61.9% was recorded on days 91–97 post partum 
in seronegative vaccinated dams. Despite no seroconversion rates are available in 
the literature for inactivated C. burnetii phase I vaccination of dairy cattle, simi-
lar rates have been reported for dairy sheep in northern Spain (Astobiza et al., 2011). 
In the subgroup of 70 animals, plasma C. burnetii antibody levels were 
observed to fall at parturition. This drop could be the result of antibody migration 
from peripheral blood to the mammary glands to produce colostrum (Herr et al., 
2011). However, vaccinated animals showed a less pronounced decline in anti-
bodies which remained elevated until three months post partum relative to the 
levels recorded in control cows. This could be attributable to the Th2 immune re-
sponse induced by the vaccine. 
According to other authors, C. burnetii seropositivity is a risk factor for 
bacterial shedding (Courcoul et al., 2010). Moreover, consistent with our find-
ings, seroconversion is not observed in non-vaccinated animals (Böttcher et al., 
2011; Nogareda et al., 2012) reflecting the high stability of C. burnetii antibod-
ies. Finally, all the cows included in this study delivered at term, with no vac-
cine-associated abortions observed, indicating the safety of this vaccine. 
In conclusion, the vaccination of pregnant dairy cows with an inactivated 
C. burnetii phase I vaccine at the start of the third trimester of pregnancy did not 
reduce shedding of the bacterium. Irrespective of vaccination, shedding levels 
during the postpartum period were related to fertility in response to first AI. 
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